These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6277796)

  • 1. Concentrations of cefotaxime and piperacillin in serum, subcutaneous tissue and muscle of patients undergoing dental surgery.
    Daschner FD; Silbermann M; Kluge D; Reibetanz I; Niederdellmann H
    Infection; 1981; 9(6):302. PubMed ID: 6277796
    [No Abstract]   [Full Text] [Related]  

  • 2. Penetration of piperacillin into cardiac valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery.
    Daschner FD; Just M; Spillner G; Schlosser V
    J Antimicrob Chemother; 1982 Jun; 9(6):489-92. PubMed ID: 6213596
    [No Abstract]   [Full Text] [Related]  

  • 3. Penetration of cefotaxime into heart valves, subcutaneous and muscle tissue of patients undergoing open-heart surgery.
    Just HM; Bassler M; Frank U; Spillner G; Schlosser V; Daschner F
    J Antimicrob Chemother; 1984 Oct; 14(4):431-4. PubMed ID: 6094425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Concentrations of cefotiam in serum, heart valves, muscle and adipose tissue during heart surgery].
    Just HM; Schlosser V; Spillner G; Schlürmann D; Daschner F
    Arzneimittelforschung; 1983; 33(4):578-9. PubMed ID: 6307320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Penetration of cefmenoxime into serum, gynecologic tissues, and heart valves.
    Daschner FD; Petersen EE; Frank U; Hornig D
    Am J Med; 1984 Dec; 77(6A):4-6. PubMed ID: 6097123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and tissue concentrations of intravenous cefotaxime during aortic surgery.
    Robbs JV; Kharsany A
    J Antimicrob Chemother; 1984 Sep; 14 Suppl B():113-6. PubMed ID: 6094429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoscale packed capillary liquid chromatography-electrospray ionization mass spectrometry: analysis of penicillins and cephems.
    Parker CE; Perkins JR; Tomer KB; Shida Y; O'Hara K
    J Chromatogr; 1993 Jun; 616(1):45-57. PubMed ID: 8376492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectral kinetic study of acylation and deacylation during the hydrolysis of penicillins and cefotaxime by beta-lactamase TEM-1 and the G238S mutant.
    Saves I; Burlet-Schiltz O; Maveyraud L; Samama JP; Promé JC; Masson JM
    Biochemistry; 1995 Sep; 34(37):11660-7. PubMed ID: 7547898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of piperacillin in renal failure.
    George CR; Burgoyne J; Funnell GR; Robinson P; Collignon P; Meads K; Guinness MD
    Med J Aust; 1981 Jan; 1(1):35-6. PubMed ID: 6451788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of piperacillin dose on elimination kinetics in renal impairment.
    Aronoff GR; Sloan RS; Brier ME; Luft FC
    Eur J Clin Pharmacol; 1983; 24(4):543-7. PubMed ID: 6222908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of cefotaxime in the dog.
    Guerrini VH; English PB; Filippich LJ; Schneider J; Bourne DW
    Vet Rec; 1986 Jul; 119(4):81-3. PubMed ID: 3750783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function.
    Kampf D; Borner K; Möller M; Kessel M
    Clin Pharmacol Ther; 1984 Feb; 35(2):214-20. PubMed ID: 6319069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens.
    Hoogkamp-Korstanje JA
    J Antimicrob Chemother; 1985 Sep; 16(3):327-34. PubMed ID: 3932295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum and urinary level of sodium piperacillin in patients with liver disease (author's transl)].
    Kakiuchi S; Tagawa S; Watanabe K; Kosaka Y; Takezawa H
    Jpn J Antibiot; 1982 Jan; 35(1):212-21. PubMed ID: 6461777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biliary excretion of piperacillin.
    Taylor EW; Poxon V; Alexander-Williams J; Jackson D
    J Int Med Res; 1983; 11(1):28-31. PubMed ID: 6219901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agar (disk) diffusion test susceptibility of clinical isolates of Pseudomonas aeruginosa to azlocillin, cefotaxime, cefsulodin, lamoxactam, mezlocillin, and piperacillin.
    Traub WH
    Chemotherapy; 1982; 28(4):257-60. PubMed ID: 6288329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime in human lung tissue.
    Blind R; Bikfalvi A; Seeger K; Seidel G; Savopoulos C
    Arzneimittelforschung; 1982; 32(10):1319-21. PubMed ID: 6295411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cefotaxime concentration in the prostatic tissue].
    Fujita K; Fujita HM; Fujii K; Masuda H; Ushiyama T; Tajima A; Aso Y
    Jpn J Antibiot; 1983 Jun; 36(6):1465-8. PubMed ID: 6197541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A study of prostatic tissue levels of ceftizoxime, cefoperazone and cefotaxime].
    Ikeda S; Ishibashi A; Koshiba K
    Hinyokika Kiyo; 1984 Aug; 30(8):1135-42. PubMed ID: 6083722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial activities of amicacin, azlocillin and cefotaxim in bronchial secretion and serum of children].
    Balischewski B; Kiessig R; Thal W; Köditz H
    Kinderarztl Prax; 1983 Sep; 51(9):437-40. PubMed ID: 6317938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.